top
HOME PAGE

Etiology and Pathogenesis > Granulocyte-macrophage colony-stimulating factor (GM-CSF)


Gliomas


Ulrich Herrlinger, Steffen Aulwurm, Herwig Strik, Simone Weit, Ulrike Naumann and Michael Weller
MIP-1α antagonizes the effect of a GM-CSF-enhanced subcutaneous vaccine in a mouse glioma model
Journal of Neuro-Oncology 66: 147–154, January
2004


Gliosarcoma


Jean WC, Spellman SR, Wallenfriedman MA, Flores CT, Kurtz BP, Hall WA, Low WC
Effects of combined granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2, and interleukin-12 based immunotherapy against intracranial glioma in the rat
J Neurooncol. 2004 Jan;66(1-2):39-49

 

HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
| BrainLife Newsletter |
Children's Corner | E-mail Alerts | Journals | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP bottom